Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: Enhanced elimination of the infection during disease progression?

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2860-2866

  Gao, Lei ^a   Weck, Melanie N ^a   Nieters, Alexandra ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Chronic atrophic gastritis; Helicobacter pylori; Inflammatory polymorphisms; Persistence

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; PEPSINOGEN I;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE;

AGED; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GASTRITIS, ATROPHIC; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 70350029838     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.015     Document Type: Article

References (37)

1. Correa P., Haenszel W., Cuello C., Tannenbaum S., and Archer M. A model for gastric cancer epidemiology. Lancet 2 (1975) 58-60
2. Correa P., and Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 133 (2007) 659-672
3. Brown L.M. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22 (2000) 283-297
4. Karnes Jr. W.E., Samloff I.M., Siurala M., et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 101 (1991) 167-174
5. Hatakeyama M., and Brzozowski T. Pathogenesis of Helicobacter pylori infection. Helicobacter 11 Suppl 1 (2006) 14-20
6. Liou J.M., Lin J.T., Wang H.P., et al. IL-1B-511 CT polymorphism is associated with increased host susceptibility to Helicobacter pylori infection in Chinese. Helicobacter 12 (2007) 142-149
7. Hamajima N., Shibata A., Katsuda N., et al. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer 6 (2003) 230-236
8. Hamajima N. Persistent Helicobacter pylori infection and genetic polymorphisms of the host. Nagoya J Med Sci 66 (2003) 103-117
9. Brenner H., Rothenbacher D., and Weck M.N. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 121 (2007) 2782-2786
10. Weck M.N., Stegmaier C., Rothenbacher D., and Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 26 (2007) 879-887
11. Gao L., Weck M.N., Nieters A., and Brenner H. Association between a pro-inflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany. Eur J Cancer 45 (2009) 428-434
12. Annibale B., Negrini R., Caruana P., et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 6 (2001) 225-233
13. Robinson K., Argent R.H., and Atherton J.C. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21 (2007) 237-259
14. Algood H.M., and Cover T.L. Helicobacter pylori persistence an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 19 (2006) 597-613
15. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
16. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
17. Sicinschi L.A., Lopez-Carrillo L., Camargo M.C., et al. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer 118 (2006) 649-657
18. Kato I., Canzian F., Franceschi S., et al. Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Contr 17 (2006) 1183-1191
19. Hamajima N., Katsuda N., Matsuo K., et al. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8-251TT and IL-10-819TT genotypes. Helicobacter 8 (2003) 105-110
20. Tseng F.C., Brown E.E., Maiese E.M., et al. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 11 (2006) 425-430
21. Chen W., Shu D., and Chadwick V.S. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 16 (2001) 377-383
22. Kamangar F., Cheng C., Abnet C.C., and Rabkin C.S. Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol Biomark Prev 15 (2006) 1920-1928
23. Uno M., Hamajima N., Ito L.S., et al. Helicobacter pylori seropositivity and IL-1B C-31T polymorphism among Japanese Brazilians. Int J Mol Med 10 (2002) 321-326
24. Dominici R., Cattaneo M., Malferrari G., et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54 (2002) 82-86
25. Beales I.L., and Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42 (1998) 227-234
26. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., and Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
27. Hamajima N., Matsuo K., Saito T., et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 92 (2001) 383-389
28. Hamajima N., Ito H., Matsuo K., Tajima K., and Tominaga S. Helicobacter pylori seropositivity, the interleukin 1B polymorphism, and smoking among first-visit outpatients. Asian Pacific J Cancer Prev 3 (2002) 23-28
29. Hellmig S., Titz A., Steinel S., et al. Influence of IL-1 gene cluster polymorphisms on the development of H. pylori associated gastric ulcer. Immunol Lett 100 (2005) 107-112
30. Ishikawa T., Nagata S., Ago Y., Takahashi K., and Karibe M. The central inhibitory effect of interleukin-1 on gastric acid secretion. Neurosci Lett 119 (1990) 114-117
31. Storskrubb T., Aro P., Ronkainen J., et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 43 (2008) 1448-1455
32. Dinis-Ribeiro M., Yamaki G., Miki K., Costa-Pereira A., Matsukawa M., and Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 11 (2004) 141-147
33. Andrew A., Wyatt J.I., and Dixon M.F. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 25 (1994) 317-322
34. Satoh K., Kimura K., Taniguchi Y., et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 93 (1998) 569-573
35. Machado J.C., Figueiredo C., Canedo P., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 (2003) 364-371
36. Lu W., Pan K., Zhang L., Lin D., Miao X., and You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis 26 (2005) 631-636
37. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201